Global Bacillus Coagulans Market Insights, Forecast to 2025

Bacillus Coagulans is a lactic acid-forming bacterial species within the genus Bacillus. The organism was first isolated and described as Bacillus Coagulans in 1915 by B.W. Hammer at the Iowa Agricultural Experiment Station as a cause of an outbreak of coagulation in evaporated milk packed by an Iowa condensary. Separately isolated in 1935 and described as Lactobacillus sporogenes in the fifth edition of Bergey's Manual, it exhibits characteristics typical of both genera Lactobacillus and Bacillus; its taxonomic position between the families Lactobacillaceae and Bacillaceae was often debated. However, in the seventh edition of Berge’s, it was finally transferred to the genus Bacillus. DNA-based technology was used in distinguishing between the two genera of bacteria which are morphologically similar and possess similar physiological and biochemical characteristics.
The classification of Bacillus Coagulans includes Below 100 B, 100-200 B and Above 200 B. This refers to the effective amount of viable bacteria, and B means Billion CFU/g. The proportion of 100-200 B in 2016 is about 47%.
Bacillus Coagulans is widely used in Drugs, Food, Beverage and Supplement Products. The most proportion of Bacillus Coagulans is Supplement Products, and the proportion in 2016 is 37.5%. The trend of Supplement Products is increasing.
North America is the largest consumption place, with a consumption market share nearly 38% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 26%.
Market competition is not intense. Ganeden, Sabinsa, Mitsubishi, Nebraska Cultures, Synbiotech, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The global Bacillus Coagulans market is valued at 18 million US$ in 2018 and will reach 34 million US$ by the end of 2025, growing at a CAGR of 8.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Bacillus Coagulans market based on company, product type, end user and key regions.

This report studies the global market size of Bacillus Coagulans in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Bacillus Coagulans in these regions.
This research report categorizes the global Bacillus Coagulans market by top players/brands, region, type and end user. This report also studies the global Bacillus Coagulans market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Ganeden
Sabinsa
Mitsubishi
Nebraska Cultures
Synbiotech
Syngen Biotech
Sanzyme
Microbax

Market size by Product
Below 100 B
100-200 B
Above 200 B
Market size by End User
Drugs
Food
Beverage
Supplement Products

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Bacillus Coagulans market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Bacillus Coagulans market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Bacillus Coagulans companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Bacillus Coagulans submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Bacillus Coagulans are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bacillus Coagulans market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.